Sanofi, Regeneron’s Dupixent wins positive results in chronic spontaneous urticaria

29th July 2021 Uncategorised 0

CSU is the fifth disease for which Dupixent has positive Phase III data, according to Sanofi and Regeneron

More: Sanofi, Regeneron’s Dupixent wins positive results in chronic spontaneous urticaria
Source: News